Media & Resources

Filter by

  • Type

  • Health area

  • Location

  • Topic

  • Year

  • Journal

  • Publication

  • Fact sheet & publication type

  • Clear all

IAVI Report

Rethinking antibodies for infectious diseases?

April 23, 2024

The COVID-19 experience, along with lingering manufacturing and delivery concerns, is prompting a harder look at the future of antibody-based treatment and prevention for infectious diseases.

Read more

Press Releases

Participants in Nigeria vaccinated in first-ever Phase 2 Lassa fever vaccine clinical trial, sponsored by IAVI

April 4, 2024

The CEPI-funded study will evaluate the safety, tolerability, and immunogenicity of IAVI’s single dose Lassa fever vaccine candidate

Read more

Features

World Vaccine Congress highlights IAVI’s R&D from end to end

March 29, 2024

IAVI leaders to share updates on our emerging infectious disease R&D portfolio and our work to make much-needed vaccines and antibodies globally accessible

Read more

Scientific Publications

Human IgG Fc-engineering for enhanced plasma half-life, mucosal distribution and killing of cancer cells and bacteria

Read more

Scientific Publications

Human immunoglobulin gene allelic variation impacts germline-targeting vaccine priming

Read more

IAVI Report

Don’t Stop Believin’: This year’s HIV vaccine research theme

March 14, 2024

Researchers at CROI discuss progress on the long road to developing an HIV vaccine.

Read more

IAVI Report

With syphilis, it’s yesterday once more

March 14, 2024

Infections are at the highest levels since 1950 and fear of antimicrobial resistance is fueling new concerns over this old pathogen.

Read more

In The News

After decades of failures, researchers have renewed hopes for an effective HIV vaccine

NBC News

March 6, 2024

Read more